HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

929.596

-13.788-1.46%

Number of Gainers:3

Number of Losers:6

Number of Flat:4

PE:- -

High:944.027

Open:939.834

Low:919.881

Close:943.384

Volume:30.57M

Turnover:348.49M

Market Cap:151.72B

Float Cap:114.70B

Loading ...

Fosun Pharma Gains Approval for Clinical Trial of Parkinson's Disease Treatment DM1001

Angelalign Allocates 780,300 Restricted Stock Units to Motivate Key Employees

Angelalign Grants 780,258 Rsus Under Post-ipo Share Scheme

Fosun Pharma Unit Gets China Clinical Trial Approval for Parkinson's Drug

MT Newswires Live

Shanghai Fosun Pharma - Approval from National Medical Products Administration for Clinical Trial of Dm1001 Formulation

THOMSON REUTERS

Fosun Pharma Subsidiary Gains Green Light for DM1001 Drug Trial in Parkinson's Treatment

Miricor Enterprises Schedules Annual Shareholder Meeting

Angelalign Holds Extraordinary General Meeting, Shareholders Pass Resolutions on Connected Transactions, Incentive Plans

Miricor Publishes 2025/26 Annual Report

Sinopharm Group Stock Falls 1.9% in Hong Kong

When Should You Buy Angelalign Technology Inc. (HKG:6699)?

Simply Wall St.

HAOHAI BIOTEC Executes Share Buyback, Spending Approximately HK$1.23 Million

Perfect Medical Expects HK$ 2 Million Audit Fee as it Moves to Reappoint Pwc

Sinopharm Group Stock Slides 1.7% in Hong Kong

Can Southbound Capital Inflows Spark a Rebound in HAOHAI BIOTEC After a Near-Half-Year Downturn?

Fosun Pharma Achieves Fourth Consecutive Year on China's Best Managed Companies List

HAOHAI BIOTEC Repurchases 161,000 Shares for HK$2.64 Million on July 20

Dehong Transportation Authority Successfully Ensures Logistics for First Myanmar Jewelry Fair in Ruili, China

Xuanzhu Biopharma Ordered to Pay RMB 9.33 Million in Cietac Arbitration Award

Samsara Stock And 2 Founder Led Software Picks With Real Revenue Growth

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1593/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK1593","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","market":"HK","secType":"PLATE","nameCN":"Aesthetic Medicine","latestPrice":929.59564,"timestamp":1784880483699,"preClose":943.3837,"halted":0,"volume":30567907,"delay":0,"changeRate":-0.014616,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":-13.788086,"latestTime":"07-24 16:00:00","open":939.8342,"high":944.0266,"low":919.881,"amount":348492113,"amplitude":0.025595,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1785115800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1784856600000,1784865600000],[1784869200000,1784880000000]],"pbRate":1.196935,"peRate":10.865832,"turnoverRate":0.001411,"increases":2,"decrements":7,"flats":4,"marketCap":151722124072,"floatMarketCap":114699509608},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1593\",,,,,undefined,":{"symbol":"BK1593","high":944.0266,"amplitude":0.025595,"preClose":943.3837,"low":919.881,"pbRate":"1.196935","latestPrice":929.59564,"volume":30567907,"delay":0,"open":939.8342,"prevYearClose":1094.978,"prevWeekClose":900.113,"prevMonthClose":846.145,"prevQuarterClose":846.145,"fiveDayClose":900.113,"twentyDayClose":830.907,"sixtyDayClose":1104.596,"secType":"PLATE","market":"HK","turnoverRate":0.001411,"peRate":10.865832,"marketCap":151722124072,"floatMarketCap":114699509608,"timestamp":1784880483699,"nameCN":"Aesthetic Medicine"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1593\",,,,undefined,":{"bkCode":"BK1593","up":3,"down":6,"flat":4},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1593\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1135683425","title":"Fosun Pharma Gains Approval for Clinical Trial of Parkinson's Disease Treatment DM1001","url":"https://stock-news.laohu8.com/highlight/detail?id=1135683425","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135683425?lang=en_us&edition=fundamental","pubTime":"2026-07-26 09:41","pubTimestamp":1785030095,"startTime":"0","endTime":"0","summary":"Fosun Pharma (02196) has announced that its subsidiary, Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd., has received approval from the National Medical Products Administration to conduct...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","BK0188","BK0060","02196","BMED","PSYK","MDTX","IBBQ","BK0196","BK0187","IBBJ","BK1593","BK0096","BK1191","BK0239","BK0183","BK0175","BK1515","600196","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119528328","title":"Angelalign Allocates 780,300 Restricted Stock Units to Motivate Key Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=1119528328","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119528328?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:18","pubTimestamp":1784895493,"startTime":"0","endTime":"0","summary":"ANGELALIGN (06699) has announced the grant of restricted stock units to key employees under its long-term incentive plan.On July 24, 2026, the company awarded 780,300 restricted stock units to 255...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06699","BK1583","BK1587","BK1100","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653084495","title":"Angelalign Grants 780,258 Rsus Under Post-ipo Share Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=2653084495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653084495?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:12","pubTimestamp":1784895142,"startTime":"0","endTime":"0","summary":"Angelalign grants 780,258 RSUs under post-IPO share schemeAngelalign granted 780,258 restricted share units under its post-IPO RSU scheme, covering 780,258 ordinary shares.Awarded on July 24, 2026 to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL74svmM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","BK1100","06699","BK1587","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653086304","title":"Fosun Pharma Unit Gets China Clinical Trial Approval for Parkinson's Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2653086304","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653086304?lang=en_us&edition=fundamental","pubTime":"2026-07-24 18:36","pubTimestamp":1784889377,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical's  subsidiary Fosun Wanbang  Pharmaceutical received approval from China's National Medical Products Administration to conduct a clinical trial of DM1001 Formulation for the treatment of signs and symptoms of Parkinson's disease, according to a Friday Hong Kong bourse filing.The company plans to commence a Phase I clinical trial in China once relevant conditions are met.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1515","02196","BK1191","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653088663","title":"Shanghai Fosun Pharma - Approval from National Medical Products Administration for Clinical Trial of Dm1001 Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2653088663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653088663?lang=en_us&edition=fundamental","pubTime":"2026-07-24 17:18","pubTimestamp":1784884684,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nFWN43Q0MM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0175","BK1191","BK0060","BK0096","600196","BK0188","BK0196","BK0012","BK0028","BK1515","BK1593","BK0239","BK0187","BK0183","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149585123","title":"Fosun Pharma Subsidiary Gains Green Light for DM1001 Drug Trial in Parkinson's Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1149585123","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1149585123?lang=en_us&edition=fundamental","pubTime":"2026-07-24 16:52","pubTimestamp":1784883151,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co.,Ltd. (SHA: 600196) has announced that its controlled subsidiary, Fosun Universal (Jiangsu) Pharmaceutical Group Co., Ltd., has received approval from China's...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBJ","BK0187","IBBQ","BMED","BK1593","BK0175","BK0060","600196","BK1515","BK1191","BK0188","BK0012","BK0183","BK0028","BK0096","02196","BK0239","MDTX","BK0196","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653106267","title":"Miricor Enterprises Schedules Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2653106267","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653106267?lang=en_us&edition=fundamental","pubTime":"2026-07-23 16:35","pubTimestamp":1784795754,"startTime":"0","endTime":"0","summary":"Miricor Enterprises schedules annual shareholder meetingMiricor Enterprises Holdings will hold its annual general meeting in Hong Kong on Sept. 18, 2026.Shareholders will vote on the audited financial","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL53C3md:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","01827","BK1215"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653542710","title":"Angelalign Holds Extraordinary General Meeting, Shareholders Pass Resolutions on Connected Transactions, Incentive Plans","url":"https://stock-news.laohu8.com/highlight/detail?id=2653542710","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653542710?lang=en_us&edition=fundamental","pubTime":"2026-07-23 16:33","pubTimestamp":1784795582,"startTime":"0","endTime":"0","summary":"Angelalign holds extraordinary general meeting, shareholders pass resolutions on connected transactions, incentive plansAngelalign held an extraordinary general meeting on July 23, 2026, passing all r","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL9ySV8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1587","06699","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653710546","title":"Miricor Publishes 2025/26 Annual Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2653710546","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653710546?lang=en_us&edition=fundamental","pubTime":"2026-07-23 16:32","pubTimestamp":1784795560,"startTime":"0","endTime":"0","summary":"Miricor publishes 2025/26 annual reportMiricor released its 2025/26 annual report, citing a tougher consumer backdrop in Hong Kong medical aesthetics and related retail.Management shifted away from hi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL1GXkRz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1215","01827","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653758736","title":"Sinopharm Group Stock Falls 1.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2653758736","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653758736?lang=en_us&edition=fundamental","pubTime":"2026-07-22 16:32","pubTimestamp":1784709120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 1.9% to 16.99 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 1.0% to 24892.66.This was the stock's second consecutive day of losses.Sinopharm Group Co. Ltd. closed 24% short of its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 0.1%.Trading volume totaled 5.1 million shares, compared to the 50-day average of 6.6 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 22, 2026 04:32 ET Copyright  2026 Dow Jones & Company, Inc.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK0183","BK1197","BK0060","LU1115378108.SGD","BK1500","BK0188","LU0640798160.USD","BK0187","BK4175","SHTDY","600196","01099","BK0175","BK0239","BK1191","BK0196","BK0012","BK0028","BK0096","02196","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653731780","title":"When Should You Buy Angelalign Technology Inc. (HKG:6699)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2653731780","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653731780?lang=en_us&edition=fundamental","pubTime":"2026-07-22 08:24","pubTimestamp":1784679876,"startTime":"0","endTime":"0","summary":"Angelalign Technology Inc. ( HKG:6699 ), is not the largest company out there, but it saw a double-digit share price...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/when-should-you-buy-angelalign-technology-inc-hkg6699-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-6699/angelalign-technology-shares/news/when-should-you-buy-angelalign-technology-inc-hkg6699-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1593","06699","BK1587","BK1100","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123927097","title":"HAOHAI BIOTEC Executes Share Buyback, Spending Approximately HK$1.23 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1123927097","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123927097?lang=en_us&edition=fundamental","pubTime":"2026-07-21 23:21","pubTimestamp":1784647281,"startTime":"0","endTime":"0","summary":"On July 21st, HAOHAI BIOTEC (06826) disclosed that it had repurchased 73,000 of its own shares, utilizing approximately HK$1.2254 million in the transaction.","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","BK1161","06826"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653272775","title":"Perfect Medical Expects HK$ 2 Million Audit Fee as it Moves to Reappoint Pwc","url":"https://stock-news.laohu8.com/highlight/detail?id=2653272775","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653272775?lang=en_us&edition=fundamental","pubTime":"2026-07-21 20:08","pubTimestamp":1784635715,"startTime":"0","endTime":"0","summary":"Perfect Medical expects HK$ 2 million audit fee as it moves to reappoint PwCPerfect Medical Health Management issued a supplemental clarification on its AGM circular on auditor reappointment.Pricewate","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL7w8j3p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01830","BK1215","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653227067","title":"Sinopharm Group Stock Slides 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2653227067","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653227067?lang=en_us&edition=fundamental","pubTime":"2026-07-21 16:31","pubTimestamp":1784622660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. slipped 1.7% to 17.32 Hong Kong dollars , on what proved to be an all-around mediocre trading session for the Hong Kong stock market, with the Hang Seng Index remaining mostly flat at 25132.29.Sinopharm Group Co. Ltd. closed 22% below its 52-week high of HK$22.34, which the company reached Feb. 25.The stock underperformed when compared to some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. fell 1.1%.Trading volume totaled 6.7 million shares, compared to the 50-day average of 6.6 million shares.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJuly 21, 2026 04:31 ET Copyright  2026 Dow Jones & Company, Inc.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","LU1115378108.SGD","BK0096","600196","BK1593","BK0060","BK0196","BK0175","BK0239","BK1515","BK0012","SHTDY","BK4175","02196","BK0183","BK1197","01099","LU0640798160.USD","BK1191","BK1500","BK0187","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197425410","title":"Can Southbound Capital Inflows Spark a Rebound in HAOHAI BIOTEC After a Near-Half-Year Downturn?","url":"https://stock-news.laohu8.com/highlight/detail?id=1197425410","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197425410?lang=en_us&edition=fundamental","pubTime":"2026-07-21 16:13","pubTimestamp":1784621612,"startTime":"0","endTime":"0","summary":"This year, HAOHAI BIOTEC (06826) has faced a significant decline in both its A-share and H-share prices, pressured by the evident crisis of continuous earnings deterioration and the hidden risk of...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLHK","06826","BK1161","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102125154","title":"Fosun Pharma Achieves Fourth Consecutive Year on China's Best Managed Companies List","url":"https://stock-news.laohu8.com/highlight/detail?id=1102125154","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102125154?lang=en_us&edition=fundamental","pubTime":"2026-07-20 18:11","pubTimestamp":1784542270,"startTime":"0","endTime":"0","summary":"On July 17, 2026, the results of the eighth China Best Managed Companies (BMC) project, jointly organized by Deloitte China, the Hong Kong University of Science and Technology Business School, and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK0183","BK0060","BK0187","BK0196","BK0239","BK0096","BK1593","BK1515","BK0188","BK0028","600196","BK0012","BK1191","02196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135841336","title":"HAOHAI BIOTEC Repurchases 161,000 Shares for HK$2.64 Million on July 20","url":"https://stock-news.laohu8.com/highlight/detail?id=1135841336","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135841336?lang=en_us&edition=fundamental","pubTime":"2026-07-20 17:30","pubTimestamp":1784539817,"startTime":"0","endTime":"0","summary":"HAOHAI BIOTEC (HKEX: 06826) announced the completion of a share repurchase transaction on July 20.The company purchased a total of 161,000 of its own shares, spending approximately HK$2.64 million on...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06826","BK1593"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139056095","title":"Dehong Transportation Authority Successfully Ensures Logistics for First Myanmar Jewelry Fair in Ruili, China","url":"https://stock-news.laohu8.com/highlight/detail?id=1139056095","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139056095?lang=en_us&edition=fundamental","pubTime":"2026-07-20 10:52","pubTimestamp":1784515949,"startTime":"0","endTime":"0","summary":"To promote the high-quality development of Yunnan's jade industry and establish a platform for domestic and international jade trade, the first Myanmar Jewelry Fair (China Ruili) is scheduled to take...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1593","UXI","BK1209","02135","XTN","159666"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652377251","title":"Xuanzhu Biopharma Ordered to Pay RMB 9.33 Million in Cietac Arbitration Award","url":"https://stock-news.laohu8.com/highlight/detail?id=2652377251","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652377251?lang=en_us&edition=fundamental","pubTime":"2026-07-19 18:49","pubTimestamp":1784458150,"startTime":"0","endTime":"0","summary":"Xuanzhu Biopharma ordered to pay RMB 9.33 million in CIETAC arbitration awardXuanzhu Biopharmaceutical received a final CIETAC arbitration award on July 15, 2026 over a May 21, 2021 technology transfe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260719:nNDL9lltbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02575","00460","BK1593","BK1515","BK1191","BK1600"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652576256","title":"Samsara Stock And 2 Founder Led Software Picks With Real Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2652576256","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652576256?lang=en_us&edition=fundamental","pubTime":"2026-07-19 11:34","pubTimestamp":1784432079,"startTime":"0","endTime":"0","summary":"Founder led companies can offer something many investors value in a world of shifting inflation data, mixed growth signals, and frequent policy surprises: leaders whose own reputations and long term vision are closely tied to shareholder outcomes. With global rates, energy costs, and consumer demand all pulling markets in different directions, backing founders who remain deeply invested in their business can be one way to focus on execution rather than headlines. This article highlights 3...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/software/nyse-iot/samsara/news/samsara-stock-and-2-founder-led-software-picks-with-real-rev","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/software/nyse-iot/samsara/news/samsara-stock-and-2-founder-led-software-picks-with-real-rev","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["00867","BK4613","IE00BMCWC346.EUR","SG9999015986.USD","BK4539","IE00BVYPNP33.GBP","PSIL","BK4588","IE00BYV24P56.USD","IE00BGHQDM52.EUR","BK1593","SG9999015952.SGD","SG9999004220.SGD","IOT","IOT.AU","BK1191","GHRS","IE00BVYPNQ40.USD","BK4023","LU2488822045.USD","BK4007","SG9999015978.USD","BK4585","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}]}}